Aims A novel tool for the evaluation of left ventricular (LV) systo‐diastolic function through
echo‐derived haemodynamic forces (HDFs) has been recently proposed. The present study …

… To evaluate the predictive value of echo-derived hemodynamic forces (HDF), together with
other echocardiographic, biohumoral and cardiopulmonary parameters on a) response to …

… In summary, our findings are strongly suggestive of “hemodynamic recovery” in which a … by
sacubitril/valsartan may lead to a hemodynamic effect that may impact cardiac hemodynamic …

… by sacubitril/valsartan might be mediated by changes in echocardiographically-defined
hemodynamic … in patients treated with sacubitril/valsartan and improved hemodynamic profile. …

… study are unlikely to be solely attributable to changes in blood pressure, but rather to
sacubitril–valsartan’s beneficial pleiotropic effects on the vascular bed and overall hemodynamics. …

Aims To evaluate the predictive value of echo-derived hemodynamic forces (HDF)
compared to other echocardiographic, biohumoral and cardiopulmonary parameters on: a) …

… -term haemodynamic effects of sacubitril/valsartan (S/V) initiation in ambulatory patients
with chronic stable heart failure. We found that S/V sacubitril/valsartan mediated vasodilation …

… -daily sacubitril/valsartan 200 mg or olmesartan 20 mg, force titrated to double the initial
doses after 4 weeks, before primary assessment at 12 weeks. The study extended double-blind …

… functional disorder and systemic hemodynamic change, a … stress, and decreasing shear
forces. Furthermore, endothelial … heart failure: The Task Force for the diagnosis and treatment of …

… between sacubitril and valsartan by comparing hemodynamic, exercise tolerance, and
biochemical results with those resulting from monotherapies of valsartan and sacubitril in a rat HF …